Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
CODA Biotherapeutics
company
About
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $670K
- Industries
- Biotechnology,Genetics,Medical,Therapeutics
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
CODA Biotherapeutics develops a chemogenetic platform designed to modulate neuronal activity. With chemogenetics, target neuronal populations are modified using gene therapy to express a tunable ligand-gated ion channel. These ligand-gated ion channels are engineered to be highly responsive to a specific proprietary small molecule but are otherwise inactive. The interaction of the small molecule and engineered receptor allows for exquisite, dose-dependent control of the neurons to generate the therapeutic effect.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$62.67M
CODA Biotherapeutics has raised a total of
$62.67M
in funding over 2 rounds. Their latest funding was raised on
Dec 2, 2021 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 2, 2021 | Series Unknown | $28M | 1 | — | — | Detail |
| Nov 10, 2020 | Grant | $670K | 1 | — | — | Detail |
| Nov 5, 2019 | Series A | $15M | 1 |
Versant Ventures
|
— | Detail |
| Sep 12, 2018 | Series A | $19M | 1 |
Versant Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
CODA Biotherapeutics is funded by 2 investors.
Versant Ventures
and National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Versant Ventures
|
— | Series Unknown |
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
